Introduction
============

Striated muscle contraction is built on an exquisitely regulated actin cytoskeleton, where actin isoforms sort into distinct, nonoverlapping compartments. The thin filaments of sarcomeres consist of skeletal muscle α-actin (α~sk~-actin), whereas extrasarcomeric membrane compartments contain cytoplasmic γ-actin (γ~cyto~-actin; [@bib12]; [@bib46]; [@bib44]; [@bib53]). The lengths of α~sk~-actin thin filaments are determined by α~sk~-actin monomer exchange at pointed ends, which is in turn regulated by tropomodulins (Tmods), a family of tropomyosin (Tm)-binding and pointed end--capping proteins ([@bib25]; [@bib34]; [@bib33]). In contrast, it is unknown whether Tmods regulate the lengths, stability, and/or organization of γ~cyto~-actin filaments, which are proposed to fortify the sarcolemma through their interactions with dystrophin and β2-spectrin at costameres ([@bib12]; [@bib47], [@bib48]; [@bib51]; [@bib53]; [@bib63]). γ~cyto~-Actin is dispensable for skeletal muscle development, but its absence can produce muscle weakness, indicating that γ~cyto~-actin plays a role in muscle mechanical performance ([@bib56]; [@bib5]). Surprisingly, γ~cyto~-actin--deficient muscles do not exhibit sarcolemmal defects, leaving the functional role of γ~cyto~-actin in muscle membranes uncertain ([@bib56]). However, up to 10-fold up-regulation of γ~cyto~-actin has been observed in various animal models of muscular dystrophy, including dystrophin-deficient *mdx* mice, α-sarcoglycan--null mice, and golden retriever muscular dystrophy ([@bib26], [@bib27]). Thus, the importance of γ~cyto~-actin under pathological conditions suggests possible functions for γ~cyto~-actin in the structural biology of other striated muscle membranes such as the sarcoplasmic reticulum (SR).

Four Tmod isoforms could potentially regulate extrasarcomeric γ~cyto~-actin organization in skeletal muscle. Tmod1 is found predominantly in terminally differentiated postmitotic cells (such as erythrocytes, lens fiber cells, neurons, and striated muscle), Tmod2 is predominantly in neuronal tissues, Tmod3 is ubiquitous, and Tmod4 is restricted to skeletal muscle fibers ([@bib15], [@bib16]; [@bib57]; [@bib61]; [@bib2]; [@bib11]; [@bib9]). Of these isoforms, only Tmod1 and Tmod4 normally localize to thin filament pointed ends in skeletal muscle ([@bib18]; [@bib2]; [@bib24]). However, Tmod1 also colocalizes with α2-spectrin at the sarcolemma of fast muscle fibers in the chicken ([@bib2]) and can be detected at the A band/I band junction in isolated rat skeletal myofibrils ([@bib18]). Furthermore, Tmod3 localizes to the M line and regions flanking the Z line in mouse muscles ([@bib24]), which recapitulates the localizations of nonmuscle Tm4 and Tm5NM1 in the SR and intracellular membranes ([@bib29]; [@bib59], [@bib60]). Therefore, based on their localizations at structures other than thin filament pointed ends, Tmods are likely candidates for capping extrasarcomeric γ~cyto~-actin and determining γ~cyto~-actin architecture in skeletal muscle. Because Tmod1 is known to regulate the architecture of nonmuscle F-actin in the spectrin-based membrane skeletons of nonmuscle cells ([@bib43]; [@bib41]), we hypothesized that perturbation of Tmod1 expression might alter extrasarcomeric γ~cyto~-actin architecture and provide clues about the function of γ~cyto~-actin in skeletal muscle.

To address our hypothesis, we used a genetic targeting approach to delete Tmod1 from skeletal muscle. Tmod1-null mice are embryonic lethal at embryonic day (E) 9.5 ([@bib8]; [@bib19]), but we were able to rescue their lethality with a cardiac-specific transgene that places Tmod1 under the control of the α--myosin heavy chain (α-MHC) promoter (*Tmod1^−/−Tg(α^*^-*MHC--Tmod1)*^, hereafter referred to as *Tmod1^−/−Tg+^*; [@bib35]). This enabled us to study the role of Tmod1 in skeletal muscle fibers, which start to develop at about E13 in the mouse ([@bib37]). *Tmod1^−/−Tg+^* muscle generates less isometric stress than *Tmod1^+/+Tg+^* muscle, but this cannot be explained by changes in thin filament length in the absence of Tmod1, as compensatory substitution by Tmod3 and Tmod4 at thin filament pointed ends functions to maintain correct thin filament lengths ([@bib24]). This led us to speculate that the weakness of *Tmod1^−/−Tg+^* skeletal muscle may be a result of additional deficits arising from abnormalities in the extrasarcomeric actin cytoskeleton. In this study, we show that Tmod3 and γ~cyto~-actin establish an SR microdomain that is distinct from a second microdomain containing Tmod1 and Tmod4. The γ~cyto~-actin/Tmod3 microdomain is associated with an M line complex also containing small ankyrin 1.5 (sAnk1.5) and nonmuscle Tm4 and Tm5NM1. Deletion of Tmod1 causes Tmod3 to vacate its M line SR compartment and translocate to the thin filament pointed ends, leading to altered localization of sAnk1.5, γ~cyto~-actin, Tm4, and Tm5NM1, abnormal SR morphologies, defects in Ca^2+^ handling, and an increase in sarcomere misalignment that is more pronounced in more heavily recruited muscles. Deletion of Tmod1 does not affect the organization of the β2-spectrin--ankyrin-B membrane skeleton, the desmin intermediate filament system, or the dystrophin--glycoprotein complex (DGC). We propose that Tmod3 mediates the organization of γ~cyto~-actin via binding to sAnk1.5, thereby providing SR stabilization, extrasarcomeric cytoskeletal connectivity, and a novel cytoskeletal linkage that facilitates lateral force transmission across muscle fibers.

Results
=======

A cytoskeleton containing γ~cyto~-actin, Tmods, and spectrin localizes to extrasarcomeric compartments in skeletal muscle
-------------------------------------------------------------------------------------------------------------------------

We defined the architecture of γ~cyto~-actin in wild-type skeletal muscle by immunostaining transverse cryosections of tibialis anterior (TA) and soleus muscles from 1-mo-old mice for γ~cyto~-actin and its binding partner β2-spectrin ([Fig. 1 A](#fig1){ref-type="fig"}). Capillaries dominated the γ~cyto~-actin staining at the fiber bundle level and provided an internal positive control for γ~cyto~-actin immunoreactivity, as expected from the abundance of γ~cyto~-actin in endothelial cells ([@bib23]). However, a punctate γ~cyto~-actin staining pattern was still evident within the muscle fibers. Upon higher magnification examination of single fibers, γ~cyto~-actin exhibited partial colocalization with β2-spectrin at the sarcolemma, as expected ([@bib52]; [@bib12]; [@bib42]). Importantly, γ~cyto~-actin did not colocalize at all with the myofibrils, which were identified by phalloidin staining for F-actin, confirming that the antibodies to γ~cyto~-actin did not cross react with α~sk~-actin in myofibrils. We observed instead that γ~cyto~-actin and β2-spectrin localized to the intermyofibrillar compartments, which contain vesicular and membrane systems, mitochondria, and cytoplasmic components in skeletal muscle, consistent with previous observations that spectrin forms a reticular network between myofibrils ([@bib52]; [@bib12]). Identical γ~cyto~-actin staining patterns were observed using both rabbit pAb 7577 ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib26]) and mouse mAb A8481 ([Fig. 1, B and C](#fig1){ref-type="fig"}), whose specificities were established using Western blotting on cell and tissue lysates with known actin isoform inventories ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201011128/DC1)). Phalloidin stained myofibrillar α~sk~-actin but not the compartments containing γ~cyto~-actin ([Fig. 1](#fig1){ref-type="fig"}), even though phalloidin binds F-actin regardless of its actin isoform composition ([@bib1]). We attribute this to the ∼4,500-fold greater abundance of α~sk~-actin in myofibrils compared with γ~cyto~-actin in skeletal muscle ([@bib26]), which thus predominates over the γ~cyto~-actin signal.

![**Tmods, γ~cyto~-actin, and spectrin localize to intermyofibrillar compartments in skeletal muscle.** (A--C) Transverse cryosections of 1-mo-old TA muscle fiber bundles and single fibers immunostained for γ~cyto~-actin, β2-spectrin, and F-actin (A) or γ~cyto~-actin, F-actin, and either Tmod1 (B) or Tmod3 (C). Arrowheads indicate intermyofibrillar compartments enriched for Tmods, γ~cyto~-actin, and β2-spectrin. Asterisks indicate capillaries. Bars, 25 µm.](JCB_201011128_RGB_Fig1){#fig1}

Both Tmod1 and Tmod3 have been shown to associate with extrasarcomeric structures ([@bib2]; [@bib24]). To determine the localizations of these Tmods with respect to extrasarcomeric γ~cyto~-actin, we immunostained transverse sections of TA and soleus muscle for γ~cyto~-actin and either Tmod1 or Tmod3. Both Tmod1 and Tmod3 colocalized with γ~cyto~-actin in extrasarcomeric compartments in wild-type muscle ([Fig. 1, B and C](#fig1){ref-type="fig"}), indicating that a combination of at least Tmod1 and Tmod3 can cap γ~cyto~-actin filament pointed ends in normal skeletal muscle. Capillaries exhibited the most pronounced Tmod3 fluorescence and provided an internal positive control for Tmod3 immunoreactivity, as Tmod3 is the unique Tmod isoform in the endothelial cells that comprise the microvasculature ([@bib14]).

Deletion of Tmod1 perturbs the extrasarcomeric γ~cyto~-actin cytoskeleton
-------------------------------------------------------------------------

To investigate a potential role for Tmod1 in organizing γ~cyto~-actin with respect to myofibril/sarcomere striations, we immunostained longitudinal sections of *Tmod1^−/−Tg+^* and *Tmod1^+/+Tg+^* TA muscle for γ~cyto~-actin and Tmods. In *Tmod1^+/+Tg+^* muscle, Tmod1 and Tmod4 exhibited their well-established localization at the pointed ends of phalloidin-stained thin filaments, but these Tmods also localized to fainter stripes flanking the Z line ([Figs. 2 A](#fig2){ref-type="fig"} and [S2](http://www.jcb.org/cgi/content/full/jcb.201011128/DC1)). Tmod1 fluorescence was not detectable in *Tmod1^−/−Tg+^* muscle ([Fig. 2 A](#fig2){ref-type="fig"}), as expected ([@bib24]). Tmod3 localized to the M line and to a wide stripe overlying the Z line in *Tmod1^+/+Tg+^* muscle, redistributing to thin filament pointed ends in *Tmod1^−/−Tg+^* muscle ([Fig. 2 B](#fig2){ref-type="fig"}), as shown previously ([@bib24]). Notably, γ~cyto~-actin colocalized with Tmod3 at the M line and in a wide Z line--flanking stripe in *Tmod1^+/+Tg+^* muscle ([Fig. 2 B](#fig2){ref-type="fig"}). Furthermore, γ~cyto~-actin partially colocalized with the narrow Z line--flanking Tmod1 doublets in *Tmod1^+/+Tg+^* muscle and the Z line--flanking Tmod4 doublets in both *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle ([Figs. 2 A](#fig2){ref-type="fig"} and S2). Examination of highly stretched myofibrils did not reveal any M line--associated Tmod1 or Tmod4 that might have been obscured by the bright Tmod1 or Tmod4 fluorescence at thin filament pointed ends (unpublished data). Thus, Tmod3 and γ~cyto~-actin define an extrasarcomeric compartment whose signature is an M line stripe and a wide Z line stripe, whereas Tmod1 and Tmod4 are predominantly associated with thin filament pointed ends, with a minor component localized to a second extrasarcomeric compartment whose signature is a doublet of narrow Z line--flanking stripes.

![**Tmods and γ~cyto~-actin exhibit two distinct extrasarcomeric localizations at the M line and flanking the Z line, and deletion of Tmod1 depletes γ~cyto~-actin from the M line.** (A--C) Longitudinal cryosections of 1-mo-old TA muscle fibers from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice immunostained for γ~cyto~-actin, F-actin, and either Tmod1 (A), Tmod3 (B), or β2-spectrin (C). (D and E) Quantitation of the ratio of M/Z (D) and Z/P (E) fluorescence of γ~cyto~-actin, β2-spectrin, and Tmods. Each bar reflects *n* = 91--99 myofibrils/genotype measured from three mice (six muscles)/genotype for γ~cyto~-actin, β2-spectrin, and Tmod3 or *n* = 42--83 myofibrils/genotype measured from two mice (four muscles)/genotype for Tmod1 and Tmod4. \*, P \< 0.001. M, M line; P, thin filament pointed ends; Z, Z line. Data are presented as mean ± SD. Bars, 1 µm.](JCB_201011128_RGB_Fig2){#fig2}

Although γ~cyto~-actin localized to the M line and across the Z line in both *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle, we noticed a modest attenuation of M line γ~cyto~-actin fluorescence in *Tmod1^−/−Tg+^* muscle ([Fig. 2, A--C](#fig2){ref-type="fig"}). To quantify this change, we integrated γ~cyto~-actin fluorescence intensity along line scans of myofibrils and measured the ratio of M line to Z line (M/Z) fluorescence. We found that the ratio of M/Z fluorescence decreased from ∼0.20 in *Tmod1^+/+Tg+^* muscle to ∼0.15 in *Tmod1^−/−Tg+^* muscle, a decrease of ∼25% ([Fig. 2 D](#fig2){ref-type="fig"}), which suggests that the deletion of Tmod1 and concomitant translocation of Tmod3 alter the architecture of extrasarcomeric γ~cyto~-actin in skeletal muscle. However, the total levels of γ~cyto~-actin were unchanged in *Tmod1^−/−Tg+^* muscle ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201011128/DC1)), similar to Tmod3 ([@bib24]). Interestingly, the ratio of Tmod3 M/Z fluorescence in *Tmod1^+/+Tg+^* muscle was also ∼0.20 ([Fig. 2 D](#fig2){ref-type="fig"}), indicating that γ~cyto~-actin and Tmod3 are partitioned with a similar pattern across extrasarcomeric striated compartments. Thus, γ~cyto~-actin is associated with Tmod3 in an extrasarcomeric cytoskeletal compartment overlaying the M line and in a broad band flanking the Z line.

A similar quantitative image analysis was performed for the ratio of Z line to pointed end (Z/P) fluorescence for Tmod1 in *Tmod1^+/+Tg+^* muscle, Tmod3 in *Tmod1^−/−Tg+^* muscle, and Tmod4 in both *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle. The ratio of Z/P fluorescence was ∼0.37 for all Tmods, although a modest but statistically significant decrease in Tmod4 Z/P fluorescence was observed in *Tmod1^−/−Tg+^* muscle ([Fig. 2 E](#fig2){ref-type="fig"}). This suggests that a small amount of Tmod4 is lost from the Z line--flanking doublets, redistributing to the thin filament pointed ends in the absence of Tmod1. These observations strengthen the notion that both Tmod3 and Tmod4 structurally compensate for the absence of Tmod1 by capping thin filament pointed ends ([@bib24]).

To determine whether γ~cyto~-actin and Tmod3 at the M line and spanning across the Z line were associated with a spectrin cytoskeleton, we immunostained longitudinal sections of TA muscle for γ~cyto~-actin and β2-spectrin. Both γ~cyto~-actin and β2-spectrin localized in a narrow band at the M line and in a broad band across the Z line in both *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle ([Fig. 2 C](#fig2){ref-type="fig"}). In contrast to γ~cyto~-actin, the ratio of β2-spectrin M/Z fluorescence was unchanged in *Tmod1^−/−Tg+^* muscle ([Fig. 2 D](#fig2){ref-type="fig"}). Western blotting also showed no changes in β2-spectrin levels in *Tmod1^−/−Tg+^* muscle (Fig. S3). Thus, β2-spectrin shares an extrasarcomeric compartment with γ~cyto~-actin and Tmod3, but γ~cyto~-actin alterations and Tmod3 translocation downstream of Tmod1 deletion do not perturb the extrasarcomeric spectrin network.

Tmods and γ~cyto~-actin define two distinct SR microdomains
-----------------------------------------------------------

The SR membrane system wraps around myofibrils and serves as the Ca^2+^ reservoir for muscle contraction. The SR membranes flank the Z line, where the terminal cisternae of the longitudinal SR are coupled to the transverse tubules at the triads, and are also located at the M line, where the fenestrated collar forms a sheath around the center of the sarcomere. Immunostaining of longitudinal sections of *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle revealed that two key SR-associated Ca^2+^ channels in skeletal muscle, RyR1 and sarco/ER Ca^2+^ ATPase 1 (SERCA1), localize in a striated pattern at the M line and flanking the Z line. In both *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle, RyR1 staining was predominantly enriched at the M line with fainter Z line--flanking stripes in a pattern distinct from either Tmods or γ~cyto~-actin ([Fig. 3 A](#fig3){ref-type="fig"}), whereas SERCA1 staining was present in a broad band around the Z line with a fainter M line stripe, resembling the staining patterns of γ~cyto~-actin, Tmod3, and β2-spectrin ([Fig. 3 B](#fig3){ref-type="fig"}). For both RyR1 and SERCA1, total protein levels and the ratio of M/Z fluorescence were identical in *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle (unpublished data). These data suggest that extrasarcomeric γ~cyto~-actin, Tmod3, and β2-spectrin are associated with an SR compartment also containing SERCA1, whereas Tmod1 and Tmod4 may be associated with a subdomain of the RyR1-containing SR compartment flanking the Z line. However, Tmod1 deletion affects neither the levels nor the localization of these two major SR-associated Ca^2+^ channels.

![**Extrasarcomeric structures containing γ~cyto~-actin and Tmods colocalize with the SR.** (A and B) Longitudinal cryosections of 1-mo-old TA muscle fibers from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice immunostained for RyR1, γ~cyto~-actin, and F-actin (A) and SERCA1, Tmod4, and F-actin (B). M, M line; P, thin filament pointed ends; Z, Z line. Bars, 1 µm.](JCB_201011128_RGB_Fig3){#fig3}

To discern in more detail how actins and Tmods sort across skeletal muscle compartments, we subjected *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* TA muscle homogenates to differential centrifugation and Western blotting for α~sk~-actin, RyR1, SERCA1, γ~cyto~-actin, Tmod1, Tmod3, and Tmod4 ([Fig. 4](#fig4){ref-type="fig"}). As expected from previous differential centrifugation experiments ([@bib30]; [@bib18]), ∼90% of α~sk~-actin was contained in the 1,500-*g* pellet (which mainly contains myofibrils), and the remaining 10% was in the cytosol. Both RyR1 and SERCA were predominantly in the 15,000-*g* pellet (which mainly contains membranes and organelles) and the 150,000-*g* pellet (which mainly contains microsomes and macromolecular complexes) of muscles of both genotypes. Although γ~cyto~-actin and Tmod3 were present in all fractions, they were enriched in the 15,000- and 150,000-*g* pellets, tending to cofractionate with the SR markers. Tmod1 and Tmod4 fractionated predominantly in the 1,500-*g* pellet along with the myofibrils, with smaller fractions in the 15,000-*g* pellet and cytosol. Thus, Tmod1 and Tmod4 have a biochemical fractionation signature distinct from γ~cyto~-actin and Tmod3, consistent with the distinct immunofluorescence staining signatures of Tmod1/Tmod4 versus γ~cyto~-actin/Tmod3 ([Fig. 2](#fig2){ref-type="fig"}). The fraction of Tmod3 in the 1,500-*g* myofibrillar pellet increased from ∼17% in *Tmod1^+/+Tg+^* muscle to ∼33% in *Tmod1^−/−Tg+^* muscle and was accompanied by a corresponding depletion of Tmod3 from the cytosol fraction, consistent with Tmod3 translocation to thin filament pointed ends in the absence of Tmod1 ([Fig. 2 B](#fig2){ref-type="fig"}; [@bib24]). The fraction of Tmod4 in the 1,500-*g* pellet increased from ∼46% in *Tmod1^+/+Tg+^* muscle to ∼53% in *Tmod1^−/−Tg+^* muscle, again consistent with a small amount of Tmod4 translocation to thin filament pointed ends in the absence of Tmod1 ([Fig. 2 E](#fig2){ref-type="fig"}). These results confirm that Tmod3 and Tmod4 rearrange and establish a structural compensatory mechanism in the absence of Tmod1. However, the amounts of Tmod3 and γ~cyto~-actin in the 15,000- and 150,000-*g* pellets did not change in *Tmod1^−/−Tg+^* muscle. This may be because whole-muscle homogenates and their fractions are contaminated with erythrocytes (a nonmuscle source of Tmod1) and endothelial cells (a nonmuscle source of Tmod3 and γ~cyto~-actin; [@bib15], [@bib16]; [@bib23]; [@bib9]; [@bib14]). This may have skewed the distributions of Tmod1, Tmod3, and γ~cyto~-actin in favor of the higher-speed pellets and obscured small changes in the fractionation patterns.

![**Differential centrifugation of skeletal muscle proteins reveals that Tmods and γ~cyto~-actin cofractionate with SR membranes.** (A) Western blots of TA tissue homogenate, 1,500-*g* pellet, 15,000-*g* pellet, 150,000-*g* pellet, and cytosol from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice. Loading of fractions was normalized with respect to the initial volume of the total homogenate. Blots were probed for α~sk~-actin, RyR1, SERCA1, γ~cyto~-actin, Tmod1, Tmod3, Tmod4, Tm4, and Tm5NM1. (B) Quantitation of Western blots. Each bar reflects the mean of three independent blots. The proportions of Tmod3 in the 1,500-*g* and cytosolic fractions and the proportion of Tmod4 in the 1,500-*g* fraction were significantly different between *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle (P \< 0.05 for each). Data are presented as mean ± SD.](JCB_201011128_RGB_Fig4){#fig4}

Deletion of Tmod1 alters the localization of sAnk1.5, a novel binding partner of Tmod3
--------------------------------------------------------------------------------------

To investigate whether the changes downstream of Tmod1 deletion (i.e., Tmod3 translocation to the thin filament pointed ends and perturbation of γ~cyto~-actin**)** might cause global changes in SR cytoskeletal organization, we screened localizations of SR-associated cytoskeletal proteins. Interestingly, the only protein that we found to be systemically mislocalized in *Tmod1^−/−Tg+^* muscle was sAnk1.5, a 17-kD splice variant of ankyrin-R that links the SR to the M line by binding to obscurin ([@bib3]; [@bib31]; [@bib49]; [@bib32]). In *Tmod1^+/+Tg+^* muscle, sAnk1.5 localizes predominantly to the M line as reported ([@bib3]; [@bib31]; [@bib32]), although low levels of Z line--associated sAnk1.5 could also be detected ([Fig. 5 A](#fig5){ref-type="fig"}). However, in *Tmod1^−/−Tg+^* muscle, sAnk1.5 immunostaining revealed a wide stripe overlaying the Z line that resembled the staining pattern of the γ~cyto~-actin/Tmod3 SR microdomain ([Fig. 5 A](#fig5){ref-type="fig"}). This change in localization was confirmed quantitatively by an ∼95% reduction in the ratio of sAnk1.5 M/Z fluorescence in *Tmod1^−/−Tg+^* muscle ([Fig. 5 B](#fig5){ref-type="fig"}). However, sAnk1.5 protein levels did not change in *Tmod1^−/−Tg+^* muscle ([Figs. 5 C](#fig5){ref-type="fig"} and S3). In contrast, obscurin (an sAnk1.5 binding partner) and ankyrin-B (a large canonical ankyrin isoform) had unchanged localizations in *Tmod1^−/−Tg+^* muscle, with the narrow M line and wide Z line staining patterns characteristic of the γ~cyto~-actin/Tmod3 SR microdomain ([Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201011128/DC1)) and identical to β2-spectrin ([Fig. 2 C](#fig2){ref-type="fig"}).

![**Tmod3 and γ~cyto~-actin form a complex with sAnk1.5, which appears at the Z line in the absence of Tmod1.** (A) Longitudinal cryosections of 1-mo-old TA muscle fibers from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice immunostained for γ~cyto~-actin, F-actin, and sAnk1.5. M, M line; Z, Z line. Bars, 1 µm. (B) Quantitation of the ratio of M/Z fluorescence of sAnk1.5. Each bar reflects *n* = 59--63 myofibrils/genotype measured from three mice (six muscles)/genotype. Data are presented as mean ± SD. \*\*\*, P \< 0.001. (C) Western blots of EDL tissue lysates show no changes in sAnk1.5 levels in *Tmod1^−/−Tg+^* mice. (D) Western blots of clarified muscle extract (input) coimmunoprecipitated using antibodies against sAnk1.5, Tmod1, or Tmod3 or their respective negative controls. Note the co-IP of Tmod3, γ~cyto~-actin, nonmuscle Tms, and sAnk1.5 but not Tmod1, β2-spectrin, ankyrin-B, RyR1, or SERCA1. (E) Western blots of clarified muscle extract coimmunoprecipitated using antibodies against sAnk1.5 or Tmod3 show reduced co-IP of sAnk1.5, Tmod3, and γ~cyto~-actin in *Tmod1^−/−Tg+^* muscle. (F) Quantitation of sAnk1.5, Tmod3, and γ~cyto~-actin protein ratios in coimmunoprecipitated *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle extract. Each bar reflects *n* = 3 lanes. Data are presented as mean ± SD. \*, P \< 0.05; \*\*, P \< 0.01. (G) Coomassie-stained gel of purified proteins used for GST pull-down experiments. (H) Western blots of bound and unbound fractions of Tmod1 or Tmod3 pulled down by glutathione resin alone or resin loaded with GST or GST-sAnk1.5.](JCB_201011128_RGB_Fig5){#fig5}

To understand the molecular mechanism for sAnk1.5 mislocalization in *Tmod1^−/−Tg+^* muscle, we performed coimmunoprecipitation (co-IP) experiments using muscle extracts. Tmod3 and γ~cyto~-actin coimmunoprecipitated with anti-sAnk1.5--coated beads, and, in an inverse experiment, sAnk1.5 and γ~cyto~-actin coimmunoprecipitated with anti-Tmod3--coated beads ([Fig. 5 D](#fig5){ref-type="fig"}). Tmod1 and sAnk1.5 did not coimmunoprecipitate with anti-sAnk1.5-- and anti-Tmod1--coated beads, respectively ([Fig. 5 D](#fig5){ref-type="fig"}), indicating that Tmod participation in this complex is Tmod3 specific. Moreover, neither β2-spectrin, ankyrin-B, RyR1, nor SERCA1 coimmunoprecipitated with either sAnk1.5 or Tmod3 ([Fig. 5 D](#fig5){ref-type="fig"}). Thus, sAnk1.5, Tmod3, and γ~cyto~-actin establish a novel SR-associated protein complex at the M line. Comparison of co-IPs from *Tmod1^−/−Tg+^* and *Tmod1^+/+Tg+^* muscles showed that less Tmod3 and γ~cyto~-actin were associated with anti-sAnk1.5--coated beads and, similarly, that less sAnk1.5 and γ~cyto~-actin were associated with anti-Tmod3--coated beads ([Figs. 5 \[E and F\]](#fig5){ref-type="fig"} and [S5](http://www.jcb.org/cgi/content/full/jcb.201011128/DC1)). Thus, the Tmod3--γ~cyto~-actin--sAnk1.5 complex partially dissociates when Tmod3 leaves the SR and translocates to the thin filament pointed ends in the absence of Tmod1. Furthermore, GST-sAnk1.5 pull-down experiments revealed that Tmod3 (but not Tmod1) binds directly to sAnk1.5 ([Fig. 5, G and H](#fig5){ref-type="fig"}). The sAnk1.5--Tmod3 interaction may be weak in vitro, as most of the Tmod3 incubated with GST-sAnk1.5 remained in the unbound fraction ([Fig. 5 H](#fig5){ref-type="fig"}). Regardless, direct binding of Tmod3 to GST-sAnk1.5 and co-IP of Tmod3 and γ~cyto~-actin from muscle extracts with sAnk1.5 antibodies demonstrate that Tmod3 and γ~cyto~-actin can establish direct cytoskeletal linkages to the SR via a specific SR constituent, sAnk1.5.

The SR is structurally and functionally compromised in the absence of Tmod1
---------------------------------------------------------------------------

To investigate whether the absence of Tmod1, translocation of Tmod3, disruption of γ~cyto~-actin, and mislocalization of sAnk1.5 might be accompanied by morphological changes in the SR, we performed transmission EM (TEM) on *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle. This revealed pathological swelling of the SR in *Tmod1^−/−Tg+^* muscle that was comparatively rare in *Tmod1^+/+Tg+^* muscle ([Fig. 6, A and B](#fig6){ref-type="fig"}). Closer examination of these defects revealed swollen, electron-lucent SR vesicles between myofibrils, particularly in the vicinity of Z lines ([Fig. 6, C and D](#fig6){ref-type="fig"}). Z lines and triads tended to be displaced from the regions containing swollen SR, although triad morphology appeared normal ([Fig. 6, A--D](#fig6){ref-type="fig"}). Occasional instances of mitochondrial swelling were also observed but were not significantly more abundant (0.90 ± 0.85 vs. 1.20 ± 1.15 mitochondrial defects/5,800× field in *Tmod1^+/+Tg+^* vs. *Tmod1^−/−Tg+^* muscle, respectively; P = 0.36). SR defects were approximately threefold more prevalent in *Tmod1^−/−Tg+^* muscle than in *Tmod1^+/+Tg+^* muscle ([Fig. 6 E](#fig6){ref-type="fig"}), although the frequency of SR defects in *Tmod1^−/−Tg+^* muscle was quite variable (coefficient of variation = 0.68). SR defects were focal, and the majority of the SR was intact in *Tmod1^−/−Tg+^* muscle, which may explain why RyR1 and SERCA1 immunofluorescence appeared normal in *Tmod1^−/−Tg+^* muscle ([Fig. 3](#fig3){ref-type="fig"}) despite the large number of SR defects evident by TEM. To determine whether these defects adversely impact SR Ca^2+^ handling, we used a fluorescence-based Ca^2+^ flux assay to compare SR Ca^2+^ release in suspensions of TA muscle fibers immediately after cholinergic stimulation by exogenous acetylcholine (ACh). Peak ACh-induced Ca^2+^ flux in *Tmod1^−/−Tg+^* muscle fibers was reduced by ∼15% compared with *Tmod1^+/+Tg+^* fibers ([Fig. 6 F](#fig6){ref-type="fig"}), indicating defective Ca^2+^ release, which is consistent with SR defects in the absence of Tmod1. Therefore, the absence of Tmod1, translocation of Tmod3, and disruption of γ~cyto~-actin produce defects in both the structure and function of the SR.

![**Deletion of Tmod1 produces ultrastructural defects in the SR and depresses SR Ca^2+^ release.** (A and B) TEM of 6-mo-old longitudinal EDL muscle sections from *Tmod1^+/+Tg+^* (A) and *Tmod1^−/−Tg+^* (B) mice. Bars, 1 µm. (C and D) Higher-magnification TEM of the SR of *Tmod1^+/+Tg+^* (C) and *Tmod1^−/−Tg+^* (D) muscle. M, mitochondria; T, triads. Bars, 0.5 µm. (E) Quantitation of SR defects in *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* EDL muscle at 5,800× magnification. Each bar reflects *n* = 20 images/genotype from two mice (four muscles)/genotype. (F) Ca^2+^ flux as a function of ACh concentration for *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* TA fiber suspensions. Note the reduced Ca^2+^ flux in *Tmod1^−/−Tg+^* fibers. Each data point reflects the mean of four independent experiments. Data are presented as mean ± SD. \*, P \< 0.01; \*\*, P \< 0.001.](JCB_201011128_GS_Fig6){#fig6}

Deletion of Tmod1 perturbs nonmuscle Tms in skeletal muscle
-----------------------------------------------------------

Nonmuscle Tm4 and Tm5NM1 play important physiological roles in regulating SR morphology and excitation--contraction coupling in skeletal muscle ([@bib29]; [@bib59], [@bib60]). The abnormal SR morphology and the loss of γ~cyto~-actin from the M line in the absence of Tmod1 led us to ask whether nonmuscle Tm4 and Tm5NM1 are perturbed in the absence of Tmod1. Immunostaining of longitudinal sections of *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle revealed that both Tm4 and Tm5NM1 localize to stripes at the M line and flanking the Z line, similar to γ~cyto~-actin ([Fig. 7, A and B](#fig7){ref-type="fig"}). Western blotting did not show any changes in the levels of Tm4 and Tm5NM1 in *Tmod1^−/−Tg+^* muscle ([Figs. 7 \[C and D\]](#fig7){ref-type="fig"} and S3). However, for both Tm4 and Tm5NM1, the ratio of M/Z fluorescence was ∼0.23 in *Tmod1^+/+Tg+^* muscle, decreasing by ∼25% to ∼0.18 in *Tmod1^−/−Tg+^* muscle ([Fig. 7 E](#fig7){ref-type="fig"}), which was strikingly similar to the redistribution of γ~cyto~-actin ([Fig. 2 D](#fig2){ref-type="fig"}). Therefore, the deletion of Tmod1 results in redistribution of nonmuscle Tms from the M line to the Z line, paralleling γ~cyto~-actin. Both Tm4 and Tm5NM1 cofractionated with γ~cyto~-actin and Tmod3 in the 15,000- and 150,000-*g* pellets, similar to SR markers, and a larger proportion of Tm4 than Tm5NM1 was associated with the 15,000-*g* pellet (∼41 vs. ∼29%, respectively), which was unchanged in *Tmod1^−/−Tg+^* muscle ([Fig. 4](#fig4){ref-type="fig"}). Most likely, the perturbation of nonmuscle Tms revealed by immunofluorescence may have been insufficient to change the relative proportions of the nonmuscle Tms in the SR-associated fractions. Alternatively, contamination of the muscle homogenates by nonmuscle cells may have suppressed our ability to detect changes in the sorting of Tm isoforms across muscle compartments in the absence of Tmod1, similar to the case of γ~cyto~-actin. Furthermore, both Tm4 and Tm5NM1 coimmunoprecipitated with sAnk1.5, Tmod3, and γ~cyto~-actin but not with Tmod1 ([Fig. 5 D](#fig5){ref-type="fig"}). Thus, nonmuscle Tms are associated with the γ~cyto~-actin/Tmod3 SR microdomain in skeletal muscle, including the M line Tmod3--sAnk1.5 complex, where they presumably stabilize γ~cyto~-actin filaments by binding along their sides and interacting with Tmods at γ~cyto~-actin pointed ends.

![**Deletion of Tmod1 depletes nonmuscle Tms from the M line.** (A and B) Longitudinal cryosections of 1-mo-old TA muscle fibers from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice immunostained for γ~cyto~-actin, F-actin, and either Tm4 (A) or Tm5NM1 (B). M, M line; Z, Z line. Bars, 1 µm. (C and D) Western blots of EDL tissue lysates show no changes in Tm4 (C) and Tm5NM1 (D) levels in *Tmod1^−/−Tg+^* muscle. (E) Quantitation of M/Z fluorescence of Tms. Each bar reflects *n* = 52--61 myofibrils/genotype measured from three mice (six muscles)/genotype. Data are presented as mean ± SD. \*, P \< 0.001.](JCB_201011128_RGB_Fig7){#fig7}

Deletion of Tmod1 increases sarcomere misalignment but does not perturb desmin or the DGC
-----------------------------------------------------------------------------------------

Intact cytoskeletal connections among core myofibrils, peripheral myofibrils, and sarcolemma are important for maintaining sarcomere alignment and providing efficient lateral force transmission during muscle contraction ([@bib40]; [@bib55]; [@bib36]). Because γ~cyto~-actin perturbation, Tmod3 translocation, and sAnk1.5 mislocalization in the absence of Tmod1 produce defects in the SR in the vicinity of the Z line, we used TEM of 1- and 6-mo-old muscles to examine whether *Tmod1^−/−Tg+^* muscles exhibit elevated sarcomere misalignment. TEM revealed a small and age-dependent increase in sarcomere misalignment in *Tmod1^−/−Tg+^* extensor digitorum longus (EDL) muscle, as determined by normalizing longitudinal Z line offset to sarcomere length (Δ*z/L~s~*; [Fig. 8, A--D](#fig8){ref-type="fig"}). Sarcomere misalignment was more pronounced in *Tmod1^−/−Tg+^* soleus muscle, with ∼15% of myofibrils exhibiting Δ*z/L~s~* \> 0.25, although myofibril misalignment in the soleus was less age dependent than in the EDL ([Fig. 8, A, B, E, and F](#fig8){ref-type="fig"}). Because the soleus is a slower and more heavily recruited muscle than the EDL, the magnitude of sarcomere misalignment in the absence of Tmod1 is muscle type dependent. Thus, the fortification of the SR by γ~cyto~-actin, Tmod3, sAnk1.5, and nonmuscle Tms plays a novel role in maintaining the alignment of adjacent myofibrils during muscle contraction and use.

![**Deletion of Tmod1 produces an age-dependent increase in sarcomere misalignment.** (A and B) TEM of 1- (A) and 6-mo-old (B) longitudinal EDL muscle sections from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice. Bars, 1 µm. (C--F) Frequency distribution of Δ*z/L~s~* in EDL (C and D) and soleus (E and F) muscles from 1- (C and E) and 6-mo-old (D and F) *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice. Each distribution reflects *n* = 34--72 myofibrils/genotype for 1-mo-old mice and *n* = 239--881 myofibrils/genotype for 6-mo-old mice measured from two mice/age/genotype (four muscles/age/genotype), which were collected in a single experiment.](JCB_201011128_GS_Fig8){#fig8}

Elevated sarcomere misalignment in *Tmod1^−/−Tg+^* muscle led us to ask whether the organization of the desmin intermediate filament network, which is known to mechanically align myofibrils ([@bib38]; [@bib54], [@bib55]; [@bib36]), might be altered in the absence of Tmod1. Desmin levels were unchanged in *Tmod1^−/−Tg+^* muscle ([Figs. 9 A](#fig9){ref-type="fig"} and S3), and no obvious changes in desmin localization were identified in *Tmod1^−/−Tg+^* muscle, with desmin localizing to Z lines and more faintly to M lines in both genotypes ([Fig. 9 D](#fig9){ref-type="fig"}). Desmin transmits contractile force to the sarcolemma by interacting with its binding partners at the costamere, which is composed of the DGC and other subcomplexes. The DGC is anchored by the giant protein dystrophin, an integral costamere constituent and γ~cyto~-actin--binding protein ([@bib51]; [@bib53]). Therefore, we examined whether γ~cyto~-actin alterations in the absence of Tmod1 might perturb the DGC. We found no changes in β-dystroglycan or dystrophin levels ([Figs. 9 \[B and C\]](#fig9){ref-type="fig"} and S3) or localization ([Fig. 9 E](#fig9){ref-type="fig"}) in *Tmod1^−/−Tg+^* muscle. This, and the fact that skeletal muscle--specific deletion of γ~cyto~-actin has no effect on the DGC ([@bib56]), indicates that neither normal Tmod1 levels nor correct pointed end regulation of extrasarcomeric γ~cyto~-actin by Tmod1 is required for assembly and targeting of the DGC to the sarcolemma.

![**Intact desmin intermediate filament network and DGC in the absence of Tmod1.** (A--C) Western blots of EDL tissue lysates show no changes in desmin (A), β-dystroglycan (B), and dystrophin (C) levels in *Tmod1^−/−Tg+^* mice. (D) Longitudinal cryosections of 1-mo-old TA muscle fibers from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice immunostained for desmin, Tmod4, and F-actin. M, M line; P, thin filament pointed ends; Z, Z line. Bars, 1 µm. (E) Transverse cryosections of 1-mo-old TA muscle fibers from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice immunostained for β-dystroglycan and dystrophin. Bars, 25 µm.](JCB_201011128_RGB_Fig9){#fig9}

Discussion
==========

Tmods and γ~cyto~-actin stabilize the SR
----------------------------------------

We have identified two distinct SR-associated compartments that contain γ~cyto~-actin and its binding partners. The first has a narrow M line and wide Z line--flanking signature and contains Tmod3, γ~cyto~-actin, nonmuscle Tms, β2-spectrin, ankyrin-B, and obscurin, whereas the second has a narrow Z line--flanking doublet signature and contains Tmod1 and Tmod4. The first γ~cyto~-actin compartment has a similar staining pattern as SERCA1, whereas the second γ~cyto~-actin compartment resembles the narrow RyR1 doublets flanking the Z line but not at the M line. We propose that, in *Tmod1^+/+Tg+^* muscle, extrasarcomeric γ~cyto~-actin pointed ends are predominantly capped by Tmod3, with smaller contributions from Tmod1 and Tmod4 (this study), whereas Tmod1 and Tmod4 cap thin filament pointed ends ([@bib24]). Tmod3 may regulate SR-associated γ~cyto~-actin by inhibiting the dissociation of actin monomers from pointed ends, stabilizing filaments and linking γ~cyto~-actin filament pointed ends to the SR membrane via Tmod3 binding to sAnk1.5 ([Fig. 10](#fig10){ref-type="fig"}). SR-associated γ~cyto~-actin filaments may be further stabilized by the binding of nonmuscle Tm4 and Tm5NM1, similar to Tmods in other actin filament systems ([@bib62]; [@bib43]; [@bib41]). In *Tmod1^−/−Tg+^* muscle, Tmod1 is absent from the SR, and Tmod3 redistributes from the SR to the thin filament pointed ends in sarcomeres, thus destabilizing the SR-associated γ~cyto~-actin complex of Tmod3, Tm4, and Tm5NM1 with sAnk1.5 ([Fig. 10](#fig10){ref-type="fig"}). The loss of γ~cyto~-actin--mediated connectivity in *Tmod1^−/−Tg+^* muscle may mechanically weaken the SR, producing aberrant SR swelling and depressed Ca^2+^ release. The disruption of linkages between the SR and myofibrils could then cause myofibril misalignment that becomes more pronounced as muscles are recruited more frequently, thereby imposing chronic mechanical stress on a structurally compromised cytoskeletal network.

![**Model of thin filament pointed end capping by Tmods and organization of the M line SR Tmod3--γ~cyto~-actin--sAnk1.5 complex in *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* muscle.** In *Tmod1^+/+Tg+^* muscle, thin filament pointed ends are capped by a combination of Tmod1 and Tmod4, whereas Tmod3 is predominantly associated with the SR. In *Tmod1^−/−Tg+^* muscle, Tmod3 translocates from the SR to the thin filament pointed ends, destabilizing the Tmod3--γ~cyto~-actin--sAnk1.5 complex. M, M line; Z, Z line.](JCB_201011128_RGB_Fig10){#fig10}

Our findings provide a mechanism that can explain the physiological alterations in *Tmod1^−/−Tg+^* muscle. We have shown previously that absence of Tmod1 does not alter thin filament lengths because of structural compensation by Tmod3 and Tmod4 ([@bib24]). Even though thin filament lengths are normal in *Tmod1^−/−Tg+^* muscle, *Tmod1^−/−Tg+^* muscle still exhibits depressed isometric stress production ([@bib24]). We propose that a combination of defects in Ca^2+^ release and lateral force transmission underlies this functional deficit. Our Ca^2+^ flux assays show that SR defects in the absence of Tmod1 lead to inadequate Ca^2+^ release and incomplete thin filament activation. Furthermore, when γ~cyto~-actin and the SR are disrupted in the absence of Tmod1, adjacent myofibrils become mechanically decoupled, leading to myofibril misalignment and a likely depression in the net force transmitted to the cell exterior. Either mechanism can produce a muscle phenotype whereby depressed isometric stress production and locomotor behavior lead to fiber-type reprogramming that reflects decreased use ([@bib24]).

Skeletal muscle fibers contain a nonmuscle-like, SR-associated cytoskeleton
---------------------------------------------------------------------------

Membrane adaptors such as ankyrins link spectrin--actin networks and spectrin-based membrane skeletons to membrane proteins, including SR-associated ion channels in striated muscle ([@bib6]; [@bib13]). Our data implicate Tmods as a novel class of molecules that compartmentalize the skeletal muscle SR via linkages to sAnk1.5 at the M line. sAnk1.5 is a 17-kD skeletal muscle--specific splice variant of ankyrin-R (Ank1) that lacks the N-terminal tandem repeat and spectrin-binding domains of canonical ankyrins and, in their place, contains a unique 73--amino acid--long N-terminal domain with a 22-residue hydrophobic membrane-binding sequence ([@bib22]; [@bib21]; [@bib49]). Our co-IP and immunostaining results show that Tmod3, γ~cyto~-actin, and nonmuscle Tms form a complex with sAnk1.5 at the M line that is distinct from β2-spectrin or ankyrin-B complexes and that does not contain SERCA1 or RyR1. sAnk1.5 is targeted to the M line by binding to obscurin, a giant protein that is anchored to myomesin and titin in the thick filaments ([@bib20]). We propose that Tmod3 binding to obscurin-tethered sAnk1.5 recruits γ~cyto~-actin and nonmuscle Tms to an SR microdomain at the M line. In this event, Tmod3 may interact with a site on sAnk1.5 distinct from its obscurin-binding site ([@bib7]). However, because obscurin remains at the M line in the absence of Tmod1, yet sAnk1.5 mislocalizes to the Z line when Tmod3 translocates to thin filament pointed ends, additional factors may anchor Tmod3 and sAnk1.5 to the M line SR compartment. Obscurin-null muscle also exhibits sAnk1.5 mislocalization to the Z line along with retraction of the longitudinal SR toward the Z line ([@bib32]), but SR retraction is not observed in Tmod1-null muscle ([Figs. 6](#fig6){ref-type="fig"} and [8](#fig8){ref-type="fig"}). Regardless, mislocalization of sAnk1.5 when Tmod3 vacates the M line in the absence of Tmod1 argues that the secondary rearrangement of Tmod3 in the absence of Tmod1 induces systemic SR alterations in *Tmod1^−/−Tg+^* muscle. However, the normal localizations of RyR1 and SERCA1 and the focal SR defects in *Tmod1^−/−Tg+^* muscle argue that defects may simply occur in focal sites of elevated mechanical stress that arise during muscle contraction and use.

The role that Tmod3 plays in organizing extrasarcomeric γ~cyto~-actin in the SR is analogous to the roles that Tmods play in lens fiber cells and erythrocytes, in which deletion of Tmod1 results in misregulation of membrane-associated F-actin, reduced Tm--F-actin association, and perturbation of the spectrin-based membrane skeleton, manifested physiologically as defects in cell morphology and mechanics ([@bib43]; [@bib41]). A similar result is observed in confluent cultures of polarized epithelial cells, in which short hairpin RNA--mediated knockdown of Tmod3 results in the loss of F-actin and Tm from lateral membranes, disruption of α2-spectrin, and reduction in cell height ([@bib62]). In contrast to the aforementioned studies, the M line Tmod3--γ~cyto~-actin--sAnk1.5 complex lacks β2-spectrin. Although the existence of Tmod--actin structures lacking spectrin has precedent in the lens ([@bib64]), spectrin may be absent from the Tmod3--γ~cyto~-actin--sAnk1.5 complex detected by co-IP because radioimmunoprecipitation assay (RIPA) buffer depolymerizes F-actin (unpublished data), thus eliminating β2-spectrin's F-actin attachment points, leaving only the proteins at the pointed ends of the filaments in the complex. Regardless, the sorting of γ~cyto~-actin and Tmods into extrasarcomeric SR microdomains identifies the SR as a new entry in the list of biological membrane systems whose architecture and physiology are regulated by Tmods.

Thus far, the molecular basis for the differential compartmentalization of α~sk~-actin and γ~cyto~-actin with Tmods is unclear. These actins share 93% sequence identity; their little divergence is chiefly in their eight extreme N-terminal residues in actin subdomain I. Experiments using in vitro chemical cross-linking of Tmod3 and α~sk~-actin identified residues on subdomains I and II of actin that directly interact with Tmod3 ([@bib65]). Of these residues, D24, D25, E99, and E100 are in actin subdomain I and conserved in all actin isoforms, close to actin's divergent extreme N terminus ([@bib45]), which therefore might function as a cap mediator, either enhancing or inhibiting Tmod isoform binding to subdomain I. In muscle cells, the N terminus of γ~cyto~-actin might recruit Tmod3 to the SR cytoskeleton, whereas the N terminus of α~sk~-actin might facilitate Tmod1 and Tmod4 binding to thin filament pointed ends. Alternatively, binding of Tmod3 to sAnk1.5 could specifically target Tmod3 and γ~cyto~-actin filaments to the SR. Either mechanism is consistent with the phenotype of *Tmod1^−/−Tg+^* muscle ([@bib24]; this study), in which Tmod--actin isoform interactions in skeletal muscle appear to be biochemically tuned in a manner that prioritizes α~sk~-actin thin filament length regulation over γ~cyto~-actin regulation. Such actin isoform--specific biochemistry likely arises from differential molecular interactions of various combinations of actins, Tmods, and Tms.

Multiple cytoskeletal systems align adjacent myofibrils
-------------------------------------------------------

Maintaining alignment among adjacent myofibrils is a function that has canonically been ascribed to desmin intermediate filaments ([@bib38]; [@bib54], [@bib55]; [@bib36]). Because the absence of Tmod1 and the translocation of Tmod3 lead to a reorganization of intermyofibrillar γ~cyto~-actin, sAnk1.5 mislocalization, SR defects, and increased sarcomere misalignment, the SR membrane itself, mechanically fortified by γ~cyto~-actin, is involved in aligning myofibrils. By tethering together adjacent myofibrils, the SR can reduce intermyofibrillar sliding during muscle deformation. Previous data have suggested that the C terminus of nebulin may act as a bridge between desmin and α~sk~-actin at the Z line and that desmin binding to nebulin mediates both thin filament lengths and myofibril alignment ([@bib4]; [@bib10]; [@bib58]). However, thus far, there is no evidence for a similar protein bridge between desmin and γ~cyto~-actin in the SR. Because the absence of Tmod1 does not perturb the desmin intermediate filament system (this study) or the localizations of the N and C termini of nebulin ([@bib24]), these cytoskeletal systems appear to be decoupled in terms of their biochemistry while remaining homologous in terms of their function. It is appealing to speculate that redundant and functionally homologous protein systems evolved as a fail-safe mechanism to ensure correct striated muscle function.

Implications for the phenotypes of mice with altered γ~cyto~-actin levels
-------------------------------------------------------------------------

Based on its strategic enrichment at costameres, interaction with dystrophin, and dramatic up-regulation in dystrophic muscles, extrasarcomeric γ~cyto~-actin has been thought to play a stabilizing and/or force-transmitting role at the sarcolemma ([@bib12]; [@bib51]; [@bib53]; [@bib26], [@bib27]). However, experiments involving targeted genetic perturbation of γ~cyto~-actin expression in skeletal muscle have produced inconsistent results. Skeletal muscle--specific deletion of γ~cyto~-actin produces functional deficits, corroborating a role in muscle function ([@bib56]), but the deletion of γ~cyto~-actin from *mdx* muscle does not increase the severity of the *mdx* phenotype, which makes the surprising suggestion that the stabilization of the dystrophic sarcolemma by γ~cyto~-actin may actually be dispensable ([@bib50]). Also surprising is that 2,000-fold overexpression of γ~cyto~-actin and resultant γ~cyto~-actin incorporation into thin filaments do not appear to have any obvious effects on muscle structure or performance ([@bib28]). SR defects and increased sarcomere misalignment arising from the absence of Tmod1, translocation of Tmod3, disruption of γ~cyto~-actin, and mislocalization of sAnk1.5 predict that outright deletion of γ~cyto~-actin might also produce a similar phenotype. Our data are the first to show that any actin-binding protein regulates SR-associated γ~cyto~-actin and sAnk1.5 in skeletal muscle and that this regulation stabilizes the SR and aligns adjacent myofibrils. Elucidation of γ~cyto~-actin dynamics, stability, and architecture in the context of its regulatory proteins may reconcile the inconsistent results of γ~cyto~-actin under- and overexpression experiments.

Materials and methods
=====================

Experimental animals
--------------------

The embryonic lethality of Tmod1-null mice was previously rescued with a Tmod1 transgene controlled by the cardiac α-MHC promoter (*Tg(α*-*MHC--Tmod1)*, denoted as *Tg+* in the text; [@bib35]). Tmod1-null mice with the *Tg(α*-*MHC*--*Tmod1)* transgene express Tmod1 exclusively in the heart and in no other tissues and survive into adulthood ([@bib35]; [@bib43]; [@bib24]; [@bib41]). In immunofluorescence and whole-muscle Western blot experiments, 1-mo-old *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* mice were sacrificed by halothane inhalation followed by cervical dislocation. For TEM, 1- and 6-mo-old mice were used. In muscle fractionation experiments, 6-mo-old mice were used. For Ca^2+^ release assays, 9-mo-old mice were used. Genotyping was performed by PCR as previously described ([@bib35]). All procedures were performed in accordance with animal care guidelines enforced by the Institutional Animal Care and Use Committee at The Scripps Research Institute.

Antibodies
----------

For immunostaining, the primary antibodies and dilutions used were as follows: 1 µg/ml affinity-purified rabbit polyclonal anti--human Tmod1 (R1749), rabbit polyclonal antiserum to human Tmod3 (R5168bl3c, 1:100), rabbit polyclonal antiserum to chicken Tmod4 preadsorbed by passage through a Tmod1 Sepharose column (R3577bl3c, 1:25), 0.93 µg/ml affinity-purified rabbit polyclonal anti--γ~cyto~-actin (7577; a gift from J.M. Ervasti, University of Minnesota, Minneapolis, MN), rabbit polyclonal anti--β-dystroglycan (H-242, 1:50; Santa Cruz Biotechnology, Inc.), rabbit polyclonal anti-RyR1 (AB9078, 1:100; Millipore), rabbit polyclonal anti-Tm4 (AB5449, 1:100; Millipore), 1 µg/ml rabbit polyclonal anti-sAnk1.5 (ARP42566_T100; Aviva Systems Biology), 4.4 µg/ml rabbit polyclonal anti--ankyrin-B (a gift from V. Bennett, Duke University, Durham, NC; [@bib39]), rabbit polyclonal antiobscurin (IQ-54, 1:100; a gift from S. Lange, University of California, San Diego, La Jolla, CA), sheep polyclonal anti-Tm5NM1 (AB5447, 1:100; Millipore), mouse monoclonal anti--β2-spectrin (42/B, 1:200; BD), mouse monoclonal anti-SERCA1 (VE121G9, 1:100; Santa Cruz Biotechnology, Inc.), mouse monoclonal antidystrophin (Dys2, 1:20; Millipore), mouse monoclonal antidesmin (DE-U-10, 1:100; Santa Cruz Biotechnology, Inc.), and mouse monoclonal anti--γ~cyto~-actin (A8481, 1:50; Sigma-Aldrich). Secondary antibodies and dilutions were as follows: Alexa Fluor 488--conjugated goat anti--rabbit IgG (1:200; Invitrogen), Alexa Fluor 488--conjugated donkey anti--sheep IgG (1:200; Invitrogen), Alexa Fluor 568--conjugated goat anti--mouse IgG (1:200; Invitrogen), Alexa Fluor 647--conjugated goat anti--mouse IgG (1:200; Invitrogen), and Alexa Fluor 647--conjugated donkey anti--sheep IgG (1:200; Invitrogen).

For Western blotting, the primary antibodies and dilutions used were as follows: 0.01 µg/ml affinity-purified rabbit polyclonal anti--human Tmod1 (R1749), rabbit polyclonal antiserum to human Tmod3 (R5168bl3c, 1:10,000), rabbit polyclonal antiserum to chicken Tmod4 preadsorbed by passage through a Tmod1 Sepharose column (R3577bl3c, 1:250), 0.02 µg/ml rabbit polyclonal anti--γ~cyto~-actin (7577), rabbit polyclonal anti--β-dystroglycan (H-242, 1:1,000), rabbit polyclonal anti-RyR1 (AB9078, 1:1,000), rabbit polyclonal anti-Tm4 (AB5449, 1:1,000), 0.1 µg/ml rabbit polyclonal anti-sAnk1.5 (ARP42566_T100), 0.044 µg/ml rabbit polyclonal anti--ankyrin-B, rabbit polyclonal anti-GST (Z-5, 1:1,000; Santa Cruz Biotechnology, Inc.), sheep polyclonal anti-Tm5NM1 (AB5447, 1:1,000), mouse monoclonal anti--pan-actin (C4, 1:10,000; a gift from J.L. Lessard, University of Cincinnati, Cincinnati, OH), mouse monoclonal antidesmin (DE-U-10, 1:1,000), mouse monoclonal anti--β2-spectrin (42/B, 1:2,000), mouse monoclonal anti--α-actin (HUC1-1, 1:1,000; Santa Cruz Biotechnology, Inc.), mouse monoclonal anti--γ~cyto~-actin (A8481, 1:1,000), mouse monoclonal anti-SERCA1 (VE121G9, 1:1,000), and mouse monoclonal antidystrophin (Dys2, 1:200). The secondary antibodies and dilutions used were HRP-conjugated donkey anti--rabbit IgG (1:10,000; Invitrogen), HRP-conjugated donkey anti--mouse IgG (1:10,000; Invitrogen), HRP-conjugated goat anti--rabbit IgG (1:10,000; Invitrogen), and HRP-conjugated goat anti--mouse IgG (1:10,000; Invitrogen).

Immunofluorescence staining and confocal imaging
------------------------------------------------

Mouse hindlimbs were pinned to cork, immersed in ice-cold relaxing buffer (100 mM NaCl, 2 mM KCl, 2 mM MgCl~2~, 6 mM K~3~PO~4~, 1 mM EGTA, and 0.1% glucose, pH 7.0), relaxed for 24 h at 4°C, and then fixed for 24 h at 4°C in 4% PFA in relaxing buffer. TA and soleus muscles were then excised, cryoprotected in 20% sucrose in PBS, embedded in optimal cutting temperature medium, and frozen on a metal block chilled in dry ice. Muscles were sectioned into 12-µm-thick cryosections and mounted on slides. Sections were washed in PBS + 0.1% Triton X-100 (PBST), permeabilized for 15 min in PBS + 0.3% Triton X-100, and blocked for 2 h in 4% BSA + 1% goat and/or donkey sera in PBST. Tissues were labeled with primary antibodies diluted in blocking buffer overnight at 4°C, washed in PBST, and then labeled with a fluorophore-conjugated secondary antibody mixture in blocking buffer for 2 h at RT. The secondary antibody mixture was supplemented with Hoechst 33258 (1:200; Invitrogen) and either Alexa Fluor 647--phalloidin (1:100; Invitrogen) or rhodamine--phalloidin (1:100; Invitrogen) to stain nuclei and F-actin, respectively. Tissues were then washed again in PBST, preserved in Gel/Mount aqueous mounting medium (Sigma-Aldrich), and coverslipped.

Images of single optical sections were collected on a laser-scanning confocal microscope (Radiance 2100; Bio-Rad Laboratories) mounted on a TE2000-U microscope (Nikon) using a 100×/1.4 NA oil objective lens (zoom 1 or 3) at RT. LaserSharp 2000 software (Bio-Rad Laboratories) was used during image collection. The gain and laser power were adjusted to stay within the fluorescent detector's linear range, and identical settings of the fluorescent imaging system were used to collect images of each set of stained sections from *Tmod1^+/+Tg+^* and *Tmod1^−/−Tg+^* animals. The ratios of M/Z or Z/P fluorescence were computed in ImageJ (National Institutes of Health) by placing a rectangular bounding box around three to five consecutive sarcomeres in a myofibril to generate a line scan, performing background correction using an adjacent myofibril-free region, and then integrating the areas under the fluorescence peaks corresponding to either the M line, Z line, or thin filament pointed ends. Fluorescence ratios were calculated from the grayscale single-channel TIFF images. To avoid error introduced by the nonlinearity of the fluorescence detector when collecting subthreshold or oversaturated signals, any myofibrils containing over- or underexposed pixels were excluded from the ratiometric analysis. Images were processed with Photoshop (Adobe), and image figures were constructed in Illustrator (Adobe).

Muscle sample preparation and Western blotting
----------------------------------------------

For muscle fractionation experiments, TA muscles were dissected in ice-cold relaxing buffer, relaxed for 24 h at 4°C, and homogenized with a Tissumizer (Teledyne Tekmar) in 10 vol of ice-cold rigor buffer (100 mM KCl, 2 mM MgCl~2~, 10 mM K~3~PO~4~, 1 mM EDTA, and 1 mM DTT, pH 7.0) supplemented with protease inhibitor cocktail (1:1,000; Sigma-Aldrich), as previously described ([@bib30]; [@bib18]). The homogenate was centrifuged at 1,500 *g* for 5 min at 4°C, producing a low-speed pellet rich in myofibrils. After washing the low-speed pellet four times in rigor buffer, the low-speed supernatant was centrifuged at 15,000 *g* for 15 min at 4°C, producing a medium-speed pellet rich in organelles, membranes, and other extrasarcomeric structures. The resulting medium-speed supernatant was then centrifuged at 150,000 *g* for 15 min at 4°C, producing a high-speed pellet rich in microsomes and macromolecular complexes and a high-speed supernatant containing cytosol. Pellets were solubilized by sonication in 2× SDS sample buffer and by boiling for 5 min. Total homogenate and cytosol were solubilized by vortexing in 2× SDS sample buffer and by boiling for 5 min. For sample preparation without fractionation, EDL muscles were dissected and extracted by homogenization in 4 vol (volume/wet weight) of 9.2 M urea and solubilized in 1/5 vol of 5× SDS sample buffer and by boiling for 5 min. Human erythrocyte Mg^2+^ ghosts ([@bib17]) and human umbilical vein endothelial cells (hUVECs) were solubilized by vortexing in 2× SDS sample buffer and by boiling for 5 min.

Proteins were separated via SDS-PAGE on 14% minigels and transferred to nitrocellulose in transfer buffer with 20% methanol at 4°C. For β2-spectrin, RyR1, and dystrophin blots, 8% minigels, 4--10% linear gradient minigels, and 4--15% linear gradient minigels were used, respectively, and proteins were transferred without methanol in 0.01% SDS ([@bib43]). For muscle fractionation, co-IP, and GST pull-down experiments, 4--20% linear gradient minigels were used. Blots were stained with 0.2% Ponceau S in 3% TCA to verify protein transfer, incubated in Blitz buffer (4% BSA, 10 mM NaHPO~4~, pH 7.4, 150 mM NaCl, 1 mM EDTA, and 0.2% Triton X-100) for at least 2 h at RT, and then incubated in primary antibodies diluted in Blitz overnight at 4°C. After washing in PBST, blots were incubated in either HRP-conjugated Protein A (1:10,000; Sigma-Aldrich) or HRP-conjugated secondary antibodies diluted in Blitz + 2% donkey serum for 1--2 h at RT. After washing again in PBST, protein bands were detected using ECL. Blots were exposed for a series of times (1 s--5 min), followed by scanning, densitometry, and quantification using ImageJ. Only blots with intermediate exposures on the linear region of the signal intensity versus the exposure time curve were used thereafter. When appropriate, blots were controlled for loading by stripping and reprobing for total actin, using the same detection procedure. For muscle fractionation experiments, distributions were computed by expressing the intensities of the 1,500-*g* pellet, 15,000-*g* pellet, 150,000-*g* pellet, and cytosol bands as percentages of the sum of the intensities of all four bands.

co-IP
-----

Mouse skeletal muscles were dissected in ice-cold PBS, homogenized with a Tissumizer in 10 vol of ice-cold RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and 50 mM Tris-HCl, pH 8.0) supplemented with protease inhibitor cocktail (1:1,000), and clarified by 5 min of centrifugation at 1,500 *g* to remove myofibrils. The resulting SR-enriched extract was divided into 1-ml aliquots, to which one of the following was added: 2 µg rabbit polyclonal anti-sAnk1.5 (ARP42566_T100), 2 µg rabbit polyclonal anti--human Tmod1 (R1749), 5 µl rabbit polyclonal antiserum to human Tmod3 (R5168bl3c), 2 µg of preimmune control IgG, or 5 µl of preimmune control serum. Antibody-bound protein complexes were absorbed to 100 µl μMACS Protein A--conjugated super-paramagnetic MicroBeads (Miltenyi Biotec) and incubated for 30 min on ice, followed by passage through a μColumn (Miltenyi Biotec) using a μMACS magnetic separator (Miltenyi Biotec). Beads were washed with RIPA buffer and eluted with 100 µl of 1× SDS sample buffer according to the manufacturer's instructions. The input extract (diluted in 2× SDS sample buffer) and eluted immunoprecipitates were then subjected to SDS-PAGE and Western blotting, as described in the previous section.

GST pull-down assay
-------------------

An excess (20 µl) of ProCatch glutathione resin (Miltenyi Biotec) was prewashed in binding buffer (20 mM Hepes, 60 mM NaCl, 0.5 mM EDTA, 1 mM NaN~3~, and 0.1% Tween 20, pH 7.3), and 3 µg of either GST or GST-sAnk1.5 (a gift from M.A. Ackermann and R.J. Bloch, University of Maryland School of Medicine, Baltimore, MD; [@bib7]) was loaded onto the resin by incubation for 1 h at 4°C. The beads were then washed three times by centrifugation at 1,000 *g* for 5 min, decanting the resulting supernatant, and resuspension in 1 ml of fresh binding buffer. Next, 3 µg of purified recombinant human Tmod1 or Tmod3 ([@bib65]) was added for a final concentration of 3 µg/ml Tmod and incubated for 1 h at 4°C. The beads were centrifuged at 1,000 *g* for 5 min, and the resulting supernatant (unbound fraction) was mixed with an equal volume of 2× SDS sample buffer. The beads were then washed three times, and the resulting pellet (bound fraction) was solubilized in an equal volume of 2× SDS sample buffer and clarified by centrifugation at 1,000 *g* for 5 min. Protein samples were then subjected to SDS-PAGE and either Coomassie blue staining or Western blotting, as described in the Muscle sample preparation and Western blotting section.

TEM
---

Mice were perfusion fixed in 4% PFA + 1.5% glutaraldehyde in 0.1 M cacodylate buffer on ice followed by dissection of soleus and EDL muscles and incubation for several hours in the same fixative. Fixation was continued overnight in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, and tissues were washed in cacodylate buffer, fixed further in 1% OsO~4~ in 0.1 M sodium cacodylate buffer for 2 h, again washed in cacodylate buffer, and then dehydrated in graded ethanols followed by propylene oxide and embedded in EMbed 812/Araldite (Electron Microscopy Sciences). Thick sections (1--2 µm) were cut, mounted on glass slides, and stained in toluidine blue for assessment of tissue structure and preservation on a light microscope. Subsequently, 60-nm thin sections were cut, mounted on copper slot grids coated with parlodion, and stained with uranyl acetate and lead citrate for examination on a transmission electron microscope (Philips CM100; FEI) at 80 kV. Images were collected using a charge-coupled device camera (Megaview III; Olympus).

Ca^2+^ release assay
--------------------

TA muscles were dissected in PBS, and tendons and connective tissue were carefully removed. Muscles were rinsed thoroughly in PBS, and extracellular collagen was digested by gently agitating muscles in 5 vol of 1 mg/ml collagenase in Eagle's minimal essential medium for 2 h at 37°C. Muscle fibers were then dissociated by repeated pipette aspiration. The fiber suspension was added to a solution of ACh (Sigma-Aldrich) in minimal essential medium, which was serially diluted from 0.005 M to 5 × 10^−12^ M on a 96-well plate. ACh-induced Ca^2+^ flux from the SR was measured using a Fluo-4 Direct assay kit (Invitrogen) according to the manufacturer's instructions. A plate reader quantified the results of the assay at excitation and emission wavelengths of 494 and 516 nm, respectively. The increase in Ca^2+^ flux from the baseline was normalized to baseline (ΔCa/Ca^0^) and plotted as a function of ACh concentration.

Statistics
----------

A reanalysis of previously published data ([@bib24]) revealed that the intraanimal muscle functional variability is as large as the interanimal variability. Thus, muscles from hindlimbs of the same animal were treated as independent samples. The normal distribution of data was evaluated using the Shapiro-Wilk test. Where appropriate, differences between genotype-dependent parameters were detected using the Student's *t* test. Data are presented as mean ± SD, and statistical significance was defined as P \< 0.05. Statistical analysis was performed in Excel (Microsoft).

Online supplemental material
----------------------------

Fig. S1 demonstrates the specificities of our actin isoform--specific antibodies. Fig. S2 depicts the Z line--flanking localization of Tmod4. Fig. S3 shows that the deletion of Tmod1 does not alter the levels of extrasarcomeric cytoskeletal proteins. Fig. S4 shows that the deletion of Tmod1 does not alter the localization of ankyrin-B or obscurin. Fig. S5 shows negative controls for co-IP experiments showing that the deletion of Tmod1 disrupts the Tmod3--γ~cyto~-actin--sAnk1.5 complex. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201011128/DC1>.
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